Literature DB >> 21406331

Dilation of the aortic root in mitochondrial disease patients.

Nicola Brunetti-Pierri1, Ricardo Pignatelli, Negin Fouladi, Jeffrey A Towbin, John W Belmont, William J Craigen, Lee-Jun Wong, John L Jefferies, Fernando Scaglia.   

Abstract

Mitochondrial cytopathies are genetically, clinically, and biochemically heterogeneous disorders due to defects of oxidative phosphorylation. The heart is highly energy dependent and therefore particularly vulnerable to defects of energy production. Hypertrophic and dilated cardiomyopathy and left ventricular noncompaction are the main cardiac manifestations occurring in mitochondrial cytopathies. Here we report ten patients with mitochondrial cytopathy presenting with dilation of the aorta. This clinical feature has not been previously reported to be associated with mitochondrial disease. The long term consequences of this observation are unknown and follow-up studies are needed to clarify the impact of this finding in the population of subjects with mitochondrial cytopathies. The mechanism(s) involved in the pathogenesis of this complication are unknown and may be potentially implicated also in the pathogenesis of other more common etiologies of aortic aneurysmal disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21406331     DOI: 10.1016/j.ymgme.2011.02.007

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  13 in total

1.  Late onset MELAS with m.3243A > G mutation and its association with aneurysm formation.

Authors:  Kun Zhu; Shuang Li; Huan Chen; Yao Wang; Miao Yu; Hongyan Wang; Weijie Zhao; Yunpeng Cao
Journal:  Metab Brain Dis       Date:  2017-03-21       Impact factor: 3.584

2.  Macroangiopathy is a typical phenotypic manifestation of MELAS.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Metab Brain Dis       Date:  2017-05-02       Impact factor: 3.584

Review 3.  Mitochondrial vasculopathy.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  World J Cardiol       Date:  2016-05-26

4.  Exome Sequencing Identifies Candidate Genetic Modifiers of Syndromic and Familial Thoracic Aortic Aneurysm Severity.

Authors:  Benjamin J Landis; Jeffrey A Schubert; Dongbing Lai; Anil G Jegga; Amy R Shikany; Tatiana Foroud; Stephanie M Ware; Robert B Hinton
Journal:  J Cardiovasc Transl Res       Date:  2017-05-26       Impact factor: 4.132

5.  Arterioectatic Spinal Angiopathy of Childhood: Clinical, Imaging, Laboratory, Histologic, and Genetic Description of a Novel CNS Vascular Pathology.

Authors:  T Abruzzo; R van den Berg; S Vadivelu; S W Hetts; M Dishop; P Cornejo; V Narayanan; K E Ramsey; C Coopwood; E G Medici-van den Herik; S D Roosendaal; M Lawton; S Bernes
Journal:  AJNR Am J Neuroradiol       Date:  2022-06-30       Impact factor: 4.966

Review 6.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Mitochondrial DNA mutations and cardiovascular disease.

Authors:  Alexander W Bray; Scott W Ballinger
Journal:  Curr Opin Cardiol       Date:  2017-05       Impact factor: 2.161

Review 8.  Cardiac complications in inherited mitochondrial diseases.

Authors:  Mohaddeseh Behjati; Mohammad Reza Sabri; Masood Etemadi Far; Majid Nejati
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

Review 9.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

10.  Cardiovascular homeostasis dependence on MICU2, a regulatory subunit of the mitochondrial calcium uniporter.

Authors:  Alexander G Bick; Hiroko Wakimoto; Kimberli J Kamer; Yasemin Sancak; Olga Goldberger; Anna Axelsson; Daniel M DeLaughter; Joshua M Gorham; Vamsi K Mootha; J G Seidman; Christine E Seidman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.